Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,301.50 -16.74 -0.11%
S&P 500 1,650.50 -1.31 -0.08%
Nasdaq 3,478.98 -3.20 -0.09%
Ticker Volume Price Price Delta
STOXX 50 2,686.77 -14.16 -0.52%
FTSE 100 6,347.57 -26.64 -0.42%
DAX 8,201.66 -27.85 -0.34%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Gilead Sciences Inc

+ Add to Watchlist

GILD*:MM

669.00 MXN 0.000.00%

As of 16:08:20 ET on 06/18/2013.

Company Profile for Gilead Sciences Inc (GILD*)

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

Contact Information

Gilead Sciences Inc

333 Lakeside Drive
Foster City, CA 94404
United States
Phone: 1-650-574-3000
Fax: 1-650-578-9264

Key Executives for Gilead Sciences Inc (GILD*)

John C MartinChairman/CEOJohn F MilliganPresident/COO
Norbert W BischofbergerExec VP:Research & DevelopmentKevin YoungExec VP:Commercial Operations
Gregg H AltonExec VP:Corp & Medical AffairsRobin L WashingtonSenior VP/CFO
Patrick O'BrienVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil